ClinicalTrials.Veeva

Find clinical trials for Multiple Myeloma in Ann Arbor, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Lymphoma
Hematologic Cancer
Leukemia
Cancer
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near Ann Arbor, MI, USA:

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

This research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma. ...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Drug: Elotuzumab

Phase 2

Mass General Brigham
Mass General Brigham

Ann Arbor, Michigan, United States and 5 other locations

This research study is studying a targeted therapy as a possible treatment for multiple myeloma.The names of the study drugs involv...

Enrolling
Multiple Myeloma
Drug: Trametinib
Drug: Dabrafenib

Phase 1

Mass General Brigham
Mass General Brigham

Detroit, Michigan, United States and 1 other location

The purpose of this study is to evaluate three daratumumab dose schedules in participants with Smoldering Multiple Myeloma....

Active, not recruiting
Multiple Myeloma
Drug: daratumumab

Phase 2

Janssen
Janssen

Ann Arbor, Michigan, United States and 56 other locations

this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of ION251 in patients with relapsed/refractory multiple...

Active, not recruiting
Refractory Multiple Myeloma
Relapsed Multiple Myeloma
Drug: ION251

Phase 1

Ionis Pharmaceuticals
Ionis Pharmaceuticals

Detroit, Michigan, United States of America and 5 other locations

This research study is studying a drug as a possible treatment for Monoclonal Gammopathy of Unknown Significance (MGUS) or Smoldering Multiple...

Active, not recruiting
Smoldering Multiple Myeloma
Monoclonal Gammopathy
Drug: Daratumumab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Detroit, Michigan, United States and 5 other locations

This study will be a multi-center, open-label, Phase 2 study where newly diagnosed Multiple Myeloma requiring systemic chemotherapy...

Active, not recruiting
Multiple Myeloma
Drug: Elotuzumab
Drug: Lenalidomide

Phase 2

The University of Chicago
The University of Chicago

Ann Arbor, Michigan, United States and 2 other locations

The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.

Enrolling
Multiple Myeloma
Drug: Carfilzomib
Drug: CC-92480

Phase 1, Phase 2

Celgene
Celgene

Detroit, Michigan, United States and 49 other locations

The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant...

Active, not recruiting
Multiple Myeloma
Biological: Ixazomib
Drug: Dexamethasone

Phase 2

The Washington University
The Washington University

Detroit, Michigan, United States and 9 other locations

versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Drug: Carfilzomib

Phase 3

Celgene
Celgene

Ann Arbor, Michigan, United States and 59 other locations

progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...

Active, not recruiting
Multiple Myeloma
Drug: Daratumumab SC
Drug: Daratumumab IV

Phase 3

Janssen
Janssen

Detroit, Michigan, United States and 211 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems